GlycoEra logo

GlycoEra

Glycan engineering platform for the treatment of autoimmune diseases.

3

Funding Rounds

$228.0m

Money raised

Overview

Glycan engineering platform for the treatment of autoimmune diseases.

Funding

Funding series

Funding Series Analysis

The company GlycoEra has raised a total of $228m in funding over 3 rounds.

Key Insights:

  • GlycoEra Series B Round, May 2025: $130m
  • GlycoEra Series A round, November 5, 2021: $49m
  • GlycoEra November 2021 Series A Funding Round: $49m
GlycoEra logo
GlycoEra Series B Round, May 2025 $130m
GlycoEra logo
GlycoEra Series A round, November 5, 2021 $49m
GlycoEra logo
GlycoEra November 2021 Series A Funding Round $49m

Industries

GlycoEra is active in the following industries: